Cargando…
De novo designed protein inhibitors of amyloid aggregation and seeding
Neurodegenerative diseases are characterized by the pathologic accumulation of aggregated proteins. Known as amyloid, these fibrillar aggregates include proteins such as tau and amyloid-β (Aβ) in Alzheimer’s disease (AD) and alpha-synuclein (αSyn) in Parkinson’s disease (PD). The development and spr...
Autores principales: | Murray, Kevin A., Hu, Carolyn J., Griner, Sarah L., Pan, Hope, Bowler, Jeannette T., Abskharon, Romany, Rosenberg, Gregory M., Cheng, Xinyi, Seidler, Paul M., Eisenberg, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9407671/ https://www.ncbi.nlm.nih.gov/pubmed/35969734 http://dx.doi.org/10.1073/pnas.2206240119 |
Ejemplares similares
-
Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils
por: Murray, Kevin A., et al.
Publicado: (2023) -
Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils
por: Tayeb-Fligelman, Einav, et al.
Publicado: (2023) -
Structure-based inhibitors of amyloid beta core suggest a common interface with tau
por: Griner, Sarah L, et al.
Publicado: (2019) -
Bioinformatic identification of previously unrecognized amyloidogenic proteins
por: Rosenberg, Gregory M., et al.
Publicado: (2022) -
Structure-based design of nanobodies that inhibit seeding of Alzheimer’s patient–extracted tau fibrils
por: Abskharon, Romany, et al.
Publicado: (2023)